바로가기메뉴

본문 바로가기 주메뉴 바로가기

logo

허혈성 심질환에 활용된 四逆湯의 최신 연구 동향

Recent Research Trends of Sayeok-tang Used in Ischemic Heart Disease

대한상한금궤의학회지 / The Journal of Korean Medical Association of Clinical Sanghan-Geumgwe, (P)2287-8696; (E)2288-744X
2021, v.13 no.1, pp.1-19
장일웅 (목포 청연한방병원)
홍준영 (온유한의원)
이숭인 (동신대학교)
  • 다운로드 수
  • 조회수

Abstract

keywords
Sayeok-tang, Sini decoction, SND, Aconiti Lateralis Radix Preperata, ischemic heart disease, herbal medicine, Shanghanlun, myocardial infarction

참고문헌

1.

1. Moon JJ, Ahn GS, Kim SH, Park JH, Kim DH, Choi DY, Shin YI , Ji GY, Shin SW, Ha GT, Lee SG, Kim JB, Lee GG, Kim YM. Shanghanlunjeonghae. Seoul:Publication Haneuimunhwasa. 2020:103-4,206-8,610-2,717-8.

2.

2. Lee SI, Cho HR. The comparison of Shanghanlun texts. Seoul:KMediACs. 2020:214,229.

3.

3. Hu X. Shanghanlun lecture. Paju:Fish forest publication. 2019:75-84, 498, 571.

4.

4. Feng SR. Six meridians and Diagnosis in Shanghanlun prescriptions. Gyungsan:Omniherb. 2012:360-6.

5.

5. Otsuka K. Explanation of Shanghanlun. Wonju:Publications of Euibang. 2004:170-7,425-7,452-3.

6.

6. The committee of HFS textbook. Herbal Formula Science in Korean Medicine. Seoul:Kunja Publications. 2020:484-90.

7.

7. Lee RC, Min JH. A case report of overactive bladder treated by Gamchogungang-tang, Hoiyeok-tang based on Shanghanlun provisions. KMediACS. 2013;5(1):45-52.

8.

8. Lee W, Lee S. A case report of Psoriasis treated by Hoeyeok-tang based on Shanghanlun provisions. KMediACS. 2019;11(1):83-94.

9.

9. Ha HY, Lee SJ. A case report of dyshidrotic eczema treated by Hoiyeok-tang based on Shanghanlun provisions. KMediACS. 2019;11(1):139-51.

10.

10. Do IS, Lee SJ. A Case Report of Atopic Dermatitis treated by Hoiyeok-tang based on Shanghanlun Provisions. KMediACS. 2019;11(1):73-82.

11.

11. Choi YK, Kang MS. A case report of Ge-yan-jiu & herbal medicine complex treatment on Juezheng caused by Wangyang. Korean J. Orient.Int. Med. 2007;28(1):187-92.

12.

12. Irwin S. Clinical manifestations and assessment of ischemic heart disease. Phys Ther. 1985;65(12):1806-11.

13.

13. Rezende PC, Ribas FF, Serrano CV Jr, Hueb W. Clinical significance of chronic myocardial ischemia in coronary artery disease patients. J Thorac Dis. 2019;11(3):1005-15.

14.

14. Kaski JC, Crea F, Gersh BJ, Camici PG. Reappraisal of Ischemic Heart Disease. Circulation. 2018;138(14):1463-1480.

15.

15. Jeon DS. Textbook of cardiology for medical students. Seoul:Daehan medical books. 2014:120-76.

16.

16. Jeon DS. Textbook of cardiology for medical students. Seoul:Daehan medical books. 2014:120-76.

17.

17. Kim SS, Kim HK. Pharmacotherapy for acute myocardial infarction. J Korean Med Assoc. 2021;64(2):139-51.

18.

18. Jeong MH. Percutaneous coronary intervention for coronary artery disease. J Korean Med Assoc. 2004;47:736-57.

19.

19. Jung MG, Park JY, Lee US, Kim YC, Oh YS, Lim M, Sin MG, Kim EY, Kim SJ. A case study of acute myocardiac infarction to follow cerebral infarction. Korean J. Orient. Int. Med. 2001;22(4):755-9.

20.

20. Nihon Kampo Igaku Kenkyujo. Kinki yoryaku kowa. Wonju:Ui-bang publishing company. 2003:171-8.

21.

21. Oh W, Park CA, Byun SH, Kim SC. A review study of researches on three decoctions including Fructus trichocanthis and Bulbus allii macrostemi in Geum-gwe-yo-ryak. Herbal Formula Science. 2020;28(4):407-28.

22.

22. Wu J, Yuan D, Yang M, Xia W, Zhang Z, Zhang H, Fei Y, Yang G. Sini decoction as an adjuvant therapy for angina pectoris: a systematic review of randomized controlled trials. J Tradit Chin Med. 2017;37(1):12-22.

23.

23. Liao HC, Liu Y, Zhou B. Effects of Sini decoction on the expressions of Smad2 and Smad7 in isoproterenol induced myocardial fibrosis rats. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2012;32(7):934-8.

24.

24 Liu J, Peter K, Shi D, Zhang L, Dong G, Zhang D, Breiteneder H, Bauer R, Jakowitsch J, Ma Y. Anti-inflammatory effects of the chinese herbal formula sini tang in myocardial infarction rats. Evid Based Complement Alternat Med. 2014;2014:309378.

25.

25. Liu J, Peter K, Shi D, Zhang L, Dong G, Zhang D, Breiteneder H, Jakowitsch J, Ma Y. Traditional formula, modern application:chinese medicine formula sini tang improves early ventricular remodeling and cardiac function after myocardial infarction in rats. Evid Based Complement Alternat Med. 2014;2014:141938.

26.

26. Shi Y, Liu C, Zhai J. Effect of Sini decoction on angiotensin Ⅱtransforming growth factor β1 and connective tissue growth factor in rats with myocardial fibrosis-induced banding of the abdominal aorta. J Tradit Chin Med. 2018;38(3):427-432.

27.

27. Zhu Y, Zhao J, Han Q, Wang Z, Wang Z, Dong X, Li J, Liu L, Shen X. The Effect and Mechanism of Chinese Herbal Formula Sini Tang in Heart Failure after Myocardial Infarction in Rats. Evid Based Complement Alternat Med. 2018;2018:5629342.

28.

28. Tan G, Lou Z, Liao W, Zhu Z, Dong X, Zhang W, Li W, Chai Y. Potential biomarkers in mouse myocardium of doxorubicin-induced cardiomyopathy: a metabonomic method and its application. PLoS One. 2011;6(11):e27683.

29.

29. Tan G, Liao W, Dong X, Yang G, Zhu Z, Li W, Chai Y, Lou Z. Metabonomic profiles delineate the effect of traditional Chinese medicine sini decoction on myocardial infarction in rats. PLoS One. 2012;7(4):e34157.

30.

30. Tan G, Lou Z, Liao W, Dong X, Zhu Z, Li W, Chai Y. Hydrophilic interaction and reversed-phase ultraperformance liquid chromatography TOF-MS for serum metabonomic analysis of myocardial infarction in rats and its applications. Mol Biosyst. 2012;8(2):548-56.

31.

31. Chen S, Wu Si, Li W, Chen X, Dong X, Tan G, Zhang H, Hong Z, Zhu Z, Chai Y. Investigation of the therapeutic effectiveness of active components in Sini decoction by a comprehensive GC/LC-MS based metabolomics and network pharmacology approaches. Mol Biosyst. 2014;10(12):3310-21.

32.

32. Zhou J, Ma X, Shi M, Chen C, Sun Y, Li J, Xiong Y, Chen J, Li F. Serum metabolomics analysis reveals that obvious cardioprotective effects of low dose Sini decoction against isoproterenol-induced myocardial injury in rats. Phytomedicine. 2017;31:18-31.

33.

33. Tan G, Wang X, Liu K, Dong X, Liao W, Wu H. Correlation of drug-induced and drug-related ultra-high performance liquid chromatography-mass spectrometry serum metabolomic profiles yields discovery of effective constituents of Sini decoction against myocardial ischemia in rats. Food Funct. 2018;9(11):5528-5535.

34.

34. Zhou Q, Meng P, Wang H, Dong X, Tan G. Pharmacokinetics of monoester-diterpenoid alkaloids in myocardial infarction and normal rats after oral administration of Sini decoction by microdialysis combined with liquid chromatography-tandem mass spectrometry. Biomed Chromatogr. 2019;33(1):e4406.

35.

35. Zhou Q, Meng P, Zhang Y, Chen P, Wang H, Tan G. The compatibility effects of sini decoction against doxorubicin-induced heart failure in rats revealed by mass spectrometry-based serum metabolite profiling and computational analysis. J Ethnopharmacol. 2020;252:112618.

36.

36. Li Y, Fu CM, Ren B, Liu Y, Gao F, Yang H, Peng W, Gan YX. Study on attenuate and synergistic mechanism between aconiti lateralis praeparata radix and glycyrrhizae radix for toxicity reduction based on metabonomic of MI-RI mouse cardiomyocytes. Zhongguo Zhong Yao Za Zhi. 2014;39(16):3166-71.

37.

37. Münzel T, Daiber A, Gori T. Nitrate therapy: new aspects concerning molecular action and tolerance. Circulation. 2011;123(19):2132-44.

38.

38. Münzel T, Daiber A, Gori T. More answers to the still unresolved question of nitrate tolerance. Eur Heart J. 2013;34(34):2666-73.

39.

39. Chen Z, Foster MW, Zhang J, Mao L, Rockman HA, Kawamoto T, Kitagawa K, Nakayama KI, Hess DT, Stamler JS. An essential role for mitochondrial aldehyde dehydrogenase in nitroglycerin bioactivation. Proc Natl Acad Sci U S A. 2005;102(34):12159–64.

40.

40. Gutkowska J, Jankowski M, Mukaddam-Daher S, McCann SM. Oxytocin is a cardiovascular hormone. Braz J Med Biol Res. 2000;33(6):625-33.

41.

41. Von Hoff DD, Layard MW, Basa P, Davis Jr HL, Von Hoff AL, Rozencweig M, MuggiaFM. Risk factors for doxorubicin-induced congestive heart failure. Ann Intern Med. 1979;91(5):710-7.

42.

42. Chang SC, Ren S, Rau CD, Wang JJ. Isoproterenol-Induced Heart Failure Mouse Model Using Osmotic Pump Implantation. Methods Mol Biol. 2018;1816:207-220.

43.

43. Lee Y, Sun WJ, Kim KM, Jun KS, Paik HK, Lee SY. Clinical Study on Aconitine Intoxication. The Korean Journal of Medicine. 1976;19(3):240-7.

44.

44. Na CS, Yoon YC. A study on Buja, Ohdu toxicosis. K.O.M.S. 1995;16(1):451-67.

45.

45. Kim WS, Lim SS, Kang HS, Choue CW, Kwon SK, Son JS, Bae JH. Cardiovascular aspects of aconitine poisoning. Korean Circulation J. 2000;30(7):855-60.

46.

46. Xu X, Xie X, Zhang H, Wang P, Li G, Chen J, Chen G, Cao X, Xiong L, Peng F, Peng C. Water-soluble alkaloids extracted from Aconiti Radix lateralis praeparata protect against chronic heart failure in rats via a calcium signaling pathway. Biomed Pharmacother. 2021;135:111184.

47.

47. Wang QH, Gao JH, Chen HM, Xie XF, Peng C. Transcriptomics study on mechanism of Aconiti Lateralis Radix Praeparata in treatment of rats with acute heart failure. Zhongguo Zhong Yao Za Zhi. 2019;44(1):131-40.

48.

48. Zhao D, Wang J, Cui Y, Wu X. Pharmacological effects of Chinese herb aconite (fuzi) on cardiovascular system. J Tradit Chin Med. 2012;32(3):308-13.

49.

49. Zhou G, Tang L, Zhou X, Wang T, Kou Z, Wang Z. A review on phytochemistry and pharmacological activities of the processed lateral root of Aconitum carmichaelii Debeaux. J Ethnopharmacol. 2015;160:173-93.

50.

50. Kim C, Mun DW, Jeong JG. Bibliographic study about the origin of Bu-Ja, Cho-O, Cheon-O. KMediACS. 2009;1(1):63-73.

51.

51. Kang GH, Choi GY, Kim HJ, Ju YS. A study on morphological and pattern analysis in two kinds of Aconiti Radix. Korean Journal of Oriental Medicine. 2006;12(1):23-38.

52.

52. Kim IR. The daily dose of Aconiti Lateralis Radix Preparata and Aconiti Lateralis Radix in treatise on cold damage diseases. Kor. J. Herbol. 2015;30(4):51-5.

53.

53 Mun DW, Kim C, Jeong JG, Cho HW, Ryu JH, Cho JH, Kim DS. Effects of various processing methods on the contents of aconitine in the Aconitum plants. KMediACS. 2010;2(1):99-108.

54.

54. Tong P, Wu C, Wang X, Hu H, Jin H, Li C, Zhu Y, Shan L, Xiao L. Development and assessment of a complete-detoxication strategy for Fuzi (lateral root of Aconitum carmichaeli) and its application in rheumatoid arthritis therapy. J Ethnopharmacol. 2013;146(2):562-71.

55.

55. Zhang Y, Yu L, Jin W, Fan H, Li M, Zhou T, Wan H, Yang J. Reducing toxicity and increasing efficiency: aconitine with liquiritin and glycyrrhetinic acid regulate calcium regulatory proteins in rat myocardial cell. Afr J Tradit Complement Altern Med. 2017;14(4):69-79.

56.

56. Hassanien MH. Ameliorating effects of ginger on isoproterenol-induced acute myocardial infarction in rats and its impact on cardiac nitric oxide. J Microsc Ultrastruct. 2020;8(3):96-103.

57.

57. Fakhri S, Patra JK, Das SK, Das G, Majnooni MB, Farzaei MH. Ginger and heart health: from mechanisms to therapeutics. Curr Mol Pharmacol. 2020. doi:10.2174/1874467213666201209105005.

58.

58. Li Z, Bao H, Zhang S, Ye T, Yang C, Li Y. Study on intersection and regulation mechanism of "efficacy-toxicity network" of aconite in combination environment of Sini decoction. Zhongguo Zhong Yao Za Zhi. 2015;40(4):733-8.

59.

59. Pei M, Wang S, Li J. Correlativity analysis of detoxicating effect of radix Glycyrrhizae on radix Aconiti preparata in sini decoction. Zhongguo Zhong Yao Za Zhi. 1996;21(1):50-2.

60.

60. Xie S, Zhang G, Sun G, Zhu X, Chen R,Zhang S, He L, Ye Z. Detoxication experimental study on different compatibility proportion of Aconiti Lateralis Radix Praeparata and glycyrrhizae radix et rhizoma. Zhongguo Zhong Yao Za Zhi. 2012;37(15):2210-4.

61.

61. Li B, Shen Y, Liao R, Gao G, Ke L, Zhou J, Rao P. Investigating mechanism of toxicity reduction by combination of Glycyrrhizae Radix et Rhizoma and Aconiti Lateralis Radix Preparata on terms of proteins self-assembly. Zhongguo Zhong Yao Za Zhi. 2015;40(4):661-6.

대한상한금궤의학회지